These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

401 related articles for article (PubMed ID: 16713688)

  • 61. Experimental reproduction of bluetongue virus serotype 8 clinical disease in calves.
    Dal Pozzo F; De Clercq K; Guyot H; Vandemeulebroucke E; Sarradin P; Vandenbussche F; Thiry E; Saegerman C
    Vet Microbiol; 2009 May; 136(3-4):352-8. PubMed ID: 19128895
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Analysis of the genomes of bluetongue virus serotype 10 vaccines and a recent BTV-10 isolate from Washington.
    Collisson E; Roy P
    Am J Vet Res; 1983 Feb; 44(2):235-7. PubMed ID: 6299144
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Bluetongue virus: European Community inter-laboratory comparison tests to evaluate ELISA and RT-PCR detection methods.
    Batten CA; Bachanek-Bankowska K; Bin-Tarif A; Kgosana L; Swain AJ; Corteyn M; Darpel K; Mellor PS; Elliott HG; Oura CA
    Vet Microbiol; 2008 May; 129(1-2):80-8. PubMed ID: 18093755
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Bluetongue virus: European Community proficiency test (2007) to evaluate ELISA and RT-PCR detection methods with special reference to pooling of samples.
    Batten CA; Sanders AJ; Bachanek-Bankowska K; Bin-Tarif A; Oura CA
    Vet Microbiol; 2009 Mar; 135(3-4):380-3. PubMed ID: 19013728
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Rapid detection and quantitation of Bluetongue virus (BTV) using a Molecular Beacon fluorescent probe assay.
    Orrù G; Ferrando ML; Meloni M; Liciardi M; Savini G; De Santis P
    J Virol Methods; 2006 Oct; 137(1):34-42. PubMed ID: 16876884
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Evaluation of antibody-ELISA and real-time RT-PCR for the diagnosis and profiling of bluetongue virus serotype 8 during the epidemic in Belgium in 2006.
    Vandenbussche F; Vanbinst T; Verheyden B; Van Dessel W; Demeestere L; Houdart P; Bertels G; Praet N; Berkvens D; Mintiens K; Goris N; De Clercq K
    Vet Microbiol; 2008 May; 129(1-2):15-27. PubMed ID: 18093753
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Bluetongue virus serotype 26: infection kinetics and pathogenesis in Dorset Poll sheep.
    Batten CA; Henstock MR; Bin-Tarif A; Steedman HM; Waddington S; Edwards L; Oura CA
    Vet Microbiol; 2012 May; 157(1-2):119-24. PubMed ID: 22177889
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Efficacy of vaccination for bluetongue virus serotype 8 performed shortly before challenge and implications for animal trade.
    Spedicato M; Lorusso A; Salini R; Gennaro AD; Leone A; Teodori L; Casaccia C; Portanti O; Calistri P; Giovannini A; Savini G
    Prev Vet Med; 2017 Jan; 136():49-55. PubMed ID: 28010907
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Possible routes of introduction of bluetongue virus serotype 8 into the epicentre of the 2006 epidemic in north-western Europe.
    Mintiens K; Méroc E; Mellor PS; Staubach C; Gerbier G; Elbers AR; Hendrickx G; De Clercq K
    Prev Vet Med; 2008 Oct; 87(1-2):131-44. PubMed ID: 18667252
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Effect of vaccination with an inactivated vaccine on transplacental transmission of BTV-8 in mid term pregnant ewes and heifers.
    van der Sluijs MT; Schroer-Joosten DP; Fid-Fourkour A; Vrijenhoek MP; Debyser I; Gregg DA; Dufe DM; Moulin V; Moormann RJ; de Smit AJ
    Vaccine; 2012 Jan; 30(3):647-55. PubMed ID: 22107846
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Assessment of bluetongue viraemia in sheep by real-time PCR and correlation with viral infectivity.
    Chatzinasiou E; Dovas CI; Papanastassopoulou M; Georgiadis M; Psychas V; Bouzalas I; Koumbati M; Koptopoulos G; Papadopoulos O
    J Virol Methods; 2010 Nov; 169(2):305-15. PubMed ID: 20691732
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Vaccination of cattle using monovalent modified-live vaccine against bluetongue virus serotype 2: innocuity, immunogenicity and effect on pregnancy.
    Monaco F; Bonfini B; Zaghini M; Antonucci D; Pini A; Savini G
    Vet Ital; 2004; 40(4):671-5. PubMed ID: 20422610
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Evaluation of humoral response and protective efficacy of two inactivated vaccines against bluetongue virus after vaccination of goats.
    Bréard E; Belbis G; Hamers C; Moulin V; Lilin T; Moreau F; Millemann Y; Montange C; Sailleau C; Durand B; Desprat A; Viarouge C; Hoffmann B; de Smit H; Goutebroze S; Hudelet P; Zientara S
    Vaccine; 2011 Mar; 29(13):2495-502. PubMed ID: 21256877
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Validation of a novel approach for the rapid production of immunogenic virus-like particles for bluetongue virus.
    Stewart M; Bhatia Y; Athmaran TN; Noad R; Gastaldi C; Dubois E; Russo P; Thiéry R; Sailleau C; Bréard E; Zientara S; Roy P
    Vaccine; 2010 Apr; 28(17):3047-54. PubMed ID: 19887134
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Emergence of a Novel Reassortant Strain of Bluetongue Serotype 6 in Israel, 2017: Clinical Manifestations of the Disease and Molecular Characterization.
    Golender N; Eldar A; Ehrlich M; Khinich Y; Kenigswald G; Varsano JS; Ertracht S; Abramovitz I; Assis I; Shlamovitz I; Tiomkin E; Yonay E; Sharir B; Bumbarov VY
    Viruses; 2019 Jul; 11(7):. PubMed ID: 31295819
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Field vaccination of sheep with bivalent modified-live vaccine against bluetongue virus serotypes 2 and 9: effect on milk production.
    Savini G; Monaco F; Facchinei A; Pinoni C; Salucci S; Cofini F; Di Ventura M
    Vet Ital; 2004; 40(4):627-30. PubMed ID: 20422599
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Evaluation of humoral response and protective efficacy of three inactivated vaccines against bluetongue virus serotype 8 one year after vaccination of sheep and cattle.
    Wäckerlin R; Eschbaumer M; König P; Hoffmann B; Beer M
    Vaccine; 2010 Jun; 28(27):4348-55. PubMed ID: 20438878
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Evaluation of adaptive immune responses and heterologous protection induced by inactivated bluetongue virus vaccines.
    Breard E; Belbis G; Viarouge C; Nomikou K; Haegeman A; De Clercq K; Hudelet P; Hamers C; Moreau F; Lilin T; Durand B; Mertens P; Vitour D; Sailleau C; Zientara S
    Vaccine; 2015 Jan; 33(4):512-8. PubMed ID: 25500308
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Experimental bluetongue virus infection of sheep; effect of previous vaccination: clinical and immunologic studies.
    Mahrt CR; Osburn BI
    Am J Vet Res; 1986 Jun; 47(6):1191-7. PubMed ID: 3014926
    [TBL] [Abstract][Full Text] [Related]  

  • 80. DNA vaccine prime and recombinant FPV vaccine boost: an important candidate immunization strategy to control bluetongue virus type 1.
    Li J; Yang T; Xu Q; Sun E; Feng Y; Lv S; Zhang Q; Wang H; Wu D
    Appl Microbiol Biotechnol; 2015 Oct; 99(20):8643-52. PubMed ID: 26048472
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.